Isoniazid (INH) is a crucial drug in the prevention and treatment of tuberculosis. INH is commonly known to cause derangements in liver function tests and peripheral neuropathy due to pyridoxine deficiency in slow acetylators. However, in toxic doses it is known to cause severe neurologic manifestations and acute metabolic acidosis. INH toxicity is characterized by the clinical triad of repetitive seizures unresponsive to the usual anticonvulsants, metabolic acidosis with a high anion gap and coma. Hence, the diagnosis of INH overdose should be considered in any patient who presents to Emergency medical services (EMS) with the triad. Though accidental overdose of anti-tuberculosis drugs have been reported in children and adults, acute toxicity is rare. When recognized, intravenous pyridoxine and correction of acidosis with sodium bicarbonate and supportive treatment is effective. The condition is easily treated with intravenous pyridoxine but if not treated in time could prove fatal. Unlike other poisonings, serum INH levels do not co-relate with either symptomatology or liver injury.
INTRODUCTION
Tuberculosis is the most common infectious disease in South Asia including India and cases of either accidental or suicidal overdose have been reported worldwide. 1 Peripheral neuropathy and hepatitis may occur with long term use of INH. 2 INH toxicity should be considered in patients presenting with acute CNS symptoms like refractory seizures, coma not responding to standard line of treatment and high anion gap metabolic acidosis. Especially in children already on AKT (Anti-Kochs treatment), a high index of suspicion has to be maintained. We report a case of a 30 year old male with intentional ingestion of INH and Rifampicin tablets who presented with status epilepticus and acute high anion gap metabolic acidosis. His seizures were refractory to anti-epileptic medications and responded to pyridoxine without any residual neurological features on follow up. There have been few case reports of INH induced metabolic acidosis and status epilepticus. 
CASE
A 30 year old male patient, weighing 40 kg was referred to the Medicine emergency unit with a generalised tonic clonic convulsion lasting almost 30 minutes and an alleged history of consumption of 10 tablets of a combination drug, each containing 600 mg Rifampicin (150 mg/kg) and 300 mg Isoniazid (75 mg/kg), three hours prior to hospitalization. The patient had one episode of vomiting but no hematemesis. There was no past history of convulsions or head injury. Past medical history was uneventful.
On admission, the patient had a heart rate of 140 per minute, respiratory rate of 34 per minute with acidotic breathing. On CNS examination, the patient appeared confused, moving all four limbs on deep painful stimuli (GCS-10/15, E 2 M 4 V 4 ). His pupils were bilaterally equal, symmetrical and reacting to light. The tone was normal and reflexes were brisk with bilateral extensor plantar response. There were no signs of meningeal irritation. Rests of the systems on examination were normal.
He was investigated as shown in Table 1 below. An arterial blood gas analysis showed uncompensated metabolic acidosis with a high anion gap. Routine blood counts, blood sugar, metabolic profile and chest X ray were within normal limits. Liver function tests showed mild transaminitis which normalized at 72 hours. Blood levels for isoniazid was not done due to non availability of this facility.
After stabilization, gastric lavage was done with activated charcoal. The convulsions were first controlled with intravenous lorazepam but two episodes of convulsions recurred and the patient was loaded with phenytoin (20 mg/kg) and intravenous levetiracetam (500 mg thrice a day). As convulsions persisted, midazolam infusion was initiated as per protocol. Inspite of the above status epilepticus management, seizures persisted and oral pyridoxine was administered www.ptbreports.org through nasogastric tube in the dose of 1 gram per gram of INH ingested. The metabolic acidosis was corrected with intravenous sodium bicarbonate. The seizures were controlled after six hours of giving oral pyridoxine, sensorium improved gradually and the patient was transferred to the ward after 72 hours of admission. His CSF examination and CT brain done to rule out any infectious or structural brain anomaly were normal. By Day 3, he began taking orally and oral pyridoxine was continued till 5 days. The patient was discharged on Day 7 after psychiatric counseling.
DISCUSSION
The manifestations of INH toxicity include nausea, vomiting, blurred vision and slurred speech, these usually occur between 30 minutes and 2 hours after the ingestion of a large amount of isoniazid and if not treated early then refractory seizures, unconsciousness and coma may follow. 2 Acute ingestion of INH as little as 1.5-2.0 g can cause toxicity, severe poisoning is likely to occur after ingestion of more than 80-100 mg/kg. Confusion, slurred speech, toxic psychosis and seizures may occur abruptly after acute overdose. Ingestion of more than 80 mg/kg causes severe central nervous systems and a dose of more than 125 mg/kg is lethal, if not promptly treated.
INH is rapidly absorbed from gastrointestinal tract on empty stomach and metabolised by enzyme N-acetyl transferase present in liver and intestinal mucosa. The presumed etiology of INH induced seizures involves a decrease in the availability of inhibitory gammaaminobutyric acid (GABA). Isoniazid metabolites, such as isoniazid hydrazones, inhibit pyridoxine phosphokinase, enzyme which converts pyridoxine (vitamin B-6) to its active form, pyridoxal-5-phosphate. 4 INH causes depletion of pyridoxine by two mechanisms: 1. Metabolites of INH like isoniazid hydrazones inactivate pyridoxal-5-phosphate. 2. These metabolites form complex with pyridoxine into inactive hydrazone which are then excreted in the urine. 5 Metabolic acidosis with an increased anion gap is most likely due to multiple factors like-production of lactic acidosis secondary to status epilepticus, INH metabolites interfering with conversion of lactate to pyruvate, acidic metabolites of INH and ketosis due to anaerobic fatty acid oxidation. 4 Hence, treatment of metabolic aci- 
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Treatment of INH toxicity includes initial stabilization of vital parameters, maintaining patent airway and gastric lavage followed by ingestion of activated charcoal. Intravenous pyridoxine should be administered in equal quantity of INH ingested, even in asymptomatic patients. Earlier the pyridoxine is given, better is the outcome. However, oral pyridoxine have also shown equal results in situations where intravenous pyridoxine is not available. If the quantity of ingested INH is unknown, pyridoxine in the dose of 5 gm can be safely administered in adults. Doses of oral pyridoxine may be repeated for 3-4 days, forced diuresis with frusemide/mannitol enhances the elimination of INH.
Haemodialysis and peritoneal dialysis are effective in the treatment of INH intoxication especially INH induced renal failure. 5 Although the patient had also ingested rifampicin, he did not have any associated toxic manifestations of Rifampicin. 6 Apart from the above side effects, other unusual features like hematological reactions, vasculitis, arthritic symptoms and even alopecia has been reported with this drug. Alopecia due to INH is very uncommon and has not been addressed in standard text books. The above features should be kept in mind as they are reversible on drug withdrawal and some of them (e.g-alopecia) might be a cause for poor compliance. 7 Serum INH levels do not play an important role in acute management of INH intoxication because serum INH levels are not done in many of the hospitals and do not have any co-relation with either symptomatology or liver injury. No residual toxicity and neurological effects were recorded in our patient on follow-up and overall 7% mortality has been reported in the literature.
CONCLUSION
INH has been reported to cause high anion gap metabolic acidosis and seizures as a manifestation of its toxicity. Pyridoxine, sodium bicarbonate and supportive therapy has shown to be effective for INH toxicity. As Tuberculosis is very common in India, it is very important for clinicians to know the manifestations and treatment of INH toxicity due to suicidal as well as accidental ingestion in children.
